Literature DB >> 23787333

Modeling predictors, moderators and mediators of treatment outcome and resistance in depression.

Madhukar H Trivedi1.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23787333     DOI： 10.1016/j.biopsych.2013.05.009

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  17 in total

1.  Right patient, right treatment, right time: biosignatures and precision medicine in depression.

Authors:  Madhukar H Trivedi
Journal:  World Psychiatry       Date:  2016-10       Impact factor: 49.548

Review 2.  Genetic endophenotypes for insomnia of major depressive disorder and treatment-induced insomnia.

Authors:  Ibrahim Mohammed Badamasi; Munn Sann Lye; Normala Ibrahim; Johnson Stanslas
Journal:  J Neural Transm (Vienna)       Date:  2019-05-18       Impact factor: 3.575

3.  Neurocognitive effects of ketamine and association with antidepressant response in individuals with treatment-resistant depression: a randomized controlled trial.

Authors:  James W Murrough; Katherine E Burdick; Cara F Levitch; Andrew M Perez; Jess W Brallier; Lee C Chang; Alexandra Foulkes; Dennis S Charney; Sanjay J Mathew; Dan V Iosifescu
Journal:  Neuropsychopharmacology       Date:  2015-03-13       Impact factor: 7.853

4.  Exercise is an effective treatment for positive valence symptoms in major depression.

Authors:  Marisa Toups; Thomas Carmody; Tracy Greer; Chad Rethorst; Bruce Grannemann; Madhukar H Trivedi
Journal:  J Affect Disord       Date:  2016-10-15       Impact factor: 4.839

5.  Affect Following First Exercise Session as a Predictor of Treatment Response in Depression.

Authors:  Anisha M Suterwala; Chad D Rethorst; Thomas J Carmody; Tracy L Greer; Bruce D Grannemann; Manish Jha; Madhukar H Trivedi
Journal:  J Clin Psychiatry       Date:  2016-08       Impact factor: 4.384

6.  Neurocognitive predictors of antidepressant clinical response.

Authors:  Gerard E Bruder; Jorge E Alvarenga; Daniel Alschuler; Karen Abraham; John G Keilp; David J Hellerstein; Jonathan W Stewart; Patrick J McGrath
Journal:  J Affect Disord       Date:  2014-05-04       Impact factor: 4.839

7.  Establishing moderators and biosignatures of antidepressant response in clinical care (EMBARC): Rationale and design.

Authors:  Madhukar H Trivedi; Patrick J McGrath; Maurizio Fava; Ramin V Parsey; Benji T Kurian; Mary L Phillips; Maria A Oquendo; Gerard Bruder; Diego Pizzagalli; Marisa Toups; Crystal Cooper; Phil Adams; Sarah Weyandt; David W Morris; Bruce D Grannemann; R Todd Ogden; Randy Buckner; Melvin McInnis; Helena C Kraemer; Eva Petkova; Thomas J Carmody; Myrna M Weissman
Journal:  J Psychiatr Res       Date:  2016-03-15       Impact factor: 4.791

8.  Adiponectin Moderates Antidepressant Treatment Outcome in the Combining Medications to Enhance Depression Outcomes Randomized Clinical Trial.

Authors:  Jennifer L Furman; Abigail Soyombo; Andrew H Czysz; Manish K Jha; Thomas J Carmody; Brittany L Mason; Philipp E Scherer; Madhukar H Trivedi
Journal:  Pers Med Psychiatry       Date:  2018-06-21

9.  Reevaluating the Efficacy and Predictability of Antidepressant Treatments: A Symptom Clustering Approach.

Authors:  Adam M Chekroud; Ralitza Gueorguieva; Harlan M Krumholz; Madhukar H Trivedi; John H Krystal; Gregory McCarthy
Journal:  JAMA Psychiatry       Date:  2017-04-01       Impact factor: 21.596

Review 10.  Serotonergic receptor gene polymorphism and response to selective serotonin reuptake inhibitors in ethnic Malay patients with first episode of major depressive disorder.

Authors:  Ibrahim Mohammed Badamasi; Munn Sann Lye; Normala Ibrahim; Nurul Asyikin Abdul Razaq; King Hwa Ling; Johnson Stanslas
Journal:  Pharmacogenomics J       Date:  2021-03-17       Impact factor: 3.550
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.